Small molecule splicing modifiers with systemic HTT-lowering activity
Anuradha Bhattacharyya(PTC Therapeutics (United States)), Stuart W. Peltz(PTC Therapeutics (United States))
Cited by 85
Related Papers
Derepression of the Her-2 uORF is mediated by a novel post-transcriptional control mechanism in cancer cells
|Genes & Development|2006|65